Magnesium sulfate and neonatal outcomes of preterm neonates

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 12, Issue 2, 2002, Pages 118-122

  Elimian, A ^a   Verma, R ^a   Ogburn, P ^a   Wiencek, V ^a   Spitzer, A ^a   Quirk, J G ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Magnesium sulfate; Preterm neonates

Indexed keywords

MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; DRUG EFFICACY; EXPOSURE; FETUS; GESTATIONAL AGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; NEWBORN MORBIDITY; NEWBORN SEPSIS; OUTCOMES RESEARCH; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADULT; FEMALE; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; UNITED STATES;

ADULT; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MAGNESIUM SULFATE; NEW YORK; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; TOCOLYTIC AGENTS;

EID: 0036667539     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.12.2.118.122     Document Type: Article

References (19)

1. Risks and complications of tocolysis
2. Magnesium sulfate
3. The risk of pulmonary edema and colloid osmotic pressure changes during magnesium sulfate infusion
4. Evidence for magnesium sulfate as a tocolytic agent
5. Controversies in tocolytic therapy
6. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
7. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years
8. Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage
9. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants
10. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia
11. Is tocolytic magnesium sulphate associated with increased total pediatric mortality?
12. Incidence and evolution of the subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1500 g
13. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies
14. Magnesium sulfate tocolysis and risk of neonatal death
15. Antenatal magnesium exposure and neonatal demise
16. Maternal antecedents for cerebral palsy in extremely preterm babies: A case-control study
17. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants
18. Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children
19. Maternal infection and cerebral palsy in infants of normal birth weight